Organovo short position confirmed by Tilson, Bloomberg says Fund manager Whitney Tilson of Kase Capital is shorting Organovo, according to Bloomberg, citing Tilson's planned presentation for the Value Investing Congress.
News For ONVO From The Last 14 Days
Check below for free stories on ONVO the last two weeks.
Organovo enters 3D bio-printed tissue agreement with J&J unit Organovo (ONVO) announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson (JNJ), to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company’s work in 3D liver tissue for toxicity testing. Terms were not disclosed.